Position
Chief Financial Officer
Company
Terns Pharmaceuticals
Foster CityBiotechnologyHealthcareTherapeuticsPharmaceuticalBiopharmaDescription
Terns Pharmaceuticals, Inc. has announced the appointment of Andrew Gengos as chief financial officer. Mr Gengos, with 25 years of experience in finance and corporate strategy in the life sciences and biotechnology industry, will play a key role in driving the company's financial growth and success in bringing new treatment options to patients.
Quick answer
Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer (February 25, 2025). Terns Pharmaceuticals is based in Foster City, California, United States.
- Who is the new Chief Financial Officer at Terns Pharmaceuticals?
- Terns Pharmaceuticals named Andrew Gengos Chief Financial Officer, announced February 25, 2025.
- What did Terns Pharmaceuticals announce on February 25, 2025?
- Terns Pharmaceuticals, Inc. has announced the appointment of Andrew Gengos as chief financial officer. Mr Gengos, with 25 years of experience in finance and corporate strategy in the life sciences and biotechnology industry, will play a key role in driving the company's financial growth and success in bringing new treatment options to patients.
- What does Terns Pharmaceuticals do?
- Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, obesity and NASH.
- Where is Terns Pharmaceuticals based?
- Terns Pharmaceuticals is based in Foster City, California, United States.
- Which similar companies made leadership changes around the same time?
- Crinetics Pharmaceuticals (February 26, 2025), Pfizer (February 24, 2025), Bristol Myers Squibb (February 21, 2025) and Santhera Pharmaceuticals (February 10, 2025) also announced leadership changes within 45 days of Terns Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Crinetics Pharmaceuticals Appoints Tobin “Toby” Schilke as Chief Financial Officer (February 26, 2025)
- Pfizer Hires Dr. Patrizia Cavazzoni as Chief Medical Officer to Replace Dr. Aida Habtezion (February 24, 2025)
- Bristol-Myers Squibb Appoints Cari Gallman as Executive Vice President and General Counsel, Succeeding Sandra Leung (February 21, 2025)
- Santhera Pharmaceuticals Appoints Catherine Isted as CFO, Andrew Smith to Step Down (February 10, 2025)
- Daiichi Sankyo Names Hiroyuki Okuzawa as Chief Executive Officer (CEO) succeeding Sunao Manabe (January 31, 2025)
- Nurix Therapeutics appoints John Northcott as Chief Commercial Officer (January 22, 2025)
Who to call at Terns Pharmaceuticals, and when
A new leader at Terns Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Terns Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Terns Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Terns Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Terns Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Terns Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.